Queen Mary University of London Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2012
NCT01448993
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now